L2L Microarray Analysis Tool
Probes from L04A.profile.ud50 that match 5azac-tsa_hepg2_dn
| Results summary | View all lists in L2L MDB | View all genes in L04A.profile.ud50 |
L2L Microarray Analysis Tool
| Results summary | View all lists in L2L MDB | View all genes in L04A.profile.ud50 |
|
Down-regulated in human hepatoma cells (HepG2) following 24 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC) and 24 hrs treatment with both 5azaC and 500 nM trichostatin A (TSA). enrichment: 1.64-fold |
 |
 | |||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S |  |
 |
Description |
| 213698_AT | ZMYM6 | D | |
|
zinc finger, MYM-type 6 | ||||||||
| 209068_AT | HNRPDL | R | |
|
heterogeneous nuclear ribonucleoprotein D-like | ||||||||
| 201016_AT | EIF1AX | P | |
|
eukaryotic translation initiation factor 1A, X-linked | ||||||||
| 218833_AT | ZAK | G | X | P | S | |
|
sterile alpha motif and leucine zipper containing kinase AZK | |||||
| 219031_S_AT | NIP7 | |
|
nuclear import 7 homolog (S. cerevisiae) | |||||||||
| 219006_AT | C6ORF66 | |
|
||||||||||
| 202160_AT | CREBBP | X | P | R | S | |
|
CREB binding protein (Rubinstein-Taybi syndrome) | |||||
| 200874_S_AT | NOL5A | R | |
|
nucleolar protein 5A (56kDa with KKE/D repeat) | ||||||||
| 218712_AT | C1ORF109 | |
|
||||||||||
| 203023_AT | HSPC111 | |
|
hypothetical protein HSPC111 | |||||||||
| 222239_S_AT | INTS6 | R | |
|
integrator complex subunit 6 | ||||||||
| 201196_S_AT | AMD1 | |
|
adenosylmethionine decarboxylase 1 | |||||||||
| 211998_AT | H3F3B | |
|
H3 histone, family 3B (H3.3B) | |||||||||
| 200768_S_AT | MAT2A | |
|
methionine adenosyltransferase II, alpha | |||||||||
| 203492_X_AT | CEP57 | T | S | |
|
centrosomal protein 57kDa | |||||||
| 219037_AT | RRP15 | |
|
ribosomal RNA processing 15 homolog (S. cerevisiae) | |||||||||
| 201197_AT | AMD1 | |
|
adenosylmethionine decarboxylase 1 | |||||||||
| 201437_S_AT | EIF4E | P | |
|
eukaryotic translation initiation factor 4E | ||||||||
| 219496_AT | ANKRD57 | |
|
ankyrin repeat domain 57 | |||||||||